JP2022530089A5 - - Google Patents
Info
- Publication number
- JP2022530089A5 JP2022530089A5 JP2021563185A JP2021563185A JP2022530089A5 JP 2022530089 A5 JP2022530089 A5 JP 2022530089A5 JP 2021563185 A JP2021563185 A JP 2021563185A JP 2021563185 A JP2021563185 A JP 2021563185A JP 2022530089 A5 JP2022530089 A5 JP 2022530089A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antibody
- antigen
- here
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962838280P | 2019-04-24 | 2019-04-24 | |
| US62/838,280 | 2019-04-24 | ||
| PCT/US2020/029929 WO2020219959A1 (en) | 2019-04-24 | 2020-04-24 | Anti-cd45 antibody drug conjugates and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530089A JP2022530089A (ja) | 2022-06-27 |
| JP2022530089A5 true JP2022530089A5 (https=) | 2023-05-08 |
| JP7650819B2 JP7650819B2 (ja) | 2025-03-25 |
Family
ID=72940686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563185A Active JP7650819B2 (ja) | 2019-04-24 | 2020-04-24 | 抗－ｃｄ４５抗体薬物コンジュゲート及びその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220175951A1 (https=) |
| EP (1) | EP3958910A4 (https=) |
| JP (1) | JP7650819B2 (https=) |
| WO (1) | WO2020219959A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| AU2017240154B2 (en) | 2016-04-01 | 2021-08-12 | Sony Group Corporation | Ultra bright dimeric or polymeric dyes |
| WO2017177065A2 (en) | 2016-04-06 | 2017-10-12 | Sony Corporation | Ultra bright dimeric or polymeric dyes with spacing linker groups |
| EP3455300A1 (en) | 2016-05-11 | 2019-03-20 | Sony Corporation | Ultra bright dimeric or polymeric dyes |
| JP7312929B2 (ja) | 2016-07-29 | 2023-07-24 | ソニーグループ株式会社 | 超明色二量体またはポリマー色素およびその調製のための方法 |
| KR20260011205A (ko) | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
| WO2019071153A1 (en) | 2017-10-05 | 2019-04-11 | Sony Corporation | PROGRAMMABLE DENDRITIC MEDICINES |
| CN111836645A (zh) | 2017-11-16 | 2020-10-27 | 索尼公司 | 可编程的聚合药物 |
| CN111565756A (zh) | 2018-01-12 | 2020-08-21 | 索尼公司 | 包含生物活性化合物的具有刚性间隔基团的聚合物 |
| EP3737417B1 (en) | 2018-01-12 | 2025-08-27 | Sony Group Corporation | Phosphoalkyl ribose polymers comprising biologically active compounds |
| US12539334B2 (en) | 2018-01-12 | 2026-02-03 | Sony Group Corporation | Phosphoalkyl polymers comprising biologically active agents |
| KR102742386B1 (ko) | 2018-03-19 | 2024-12-16 | 소니그룹주식회사 | 형광 신호 향상을 위한 2가 금속의 사용 |
| CN118480073A (zh) | 2018-03-21 | 2024-08-13 | 索尼公司 | 具有连接体基团的聚合串联染料 |
| JP7580689B2 (ja) | 2018-06-27 | 2024-11-12 | ソニーグループ株式会社 | デオキシリボースを含むリンカー基を有するポリマー色素 |
| KR20210032434A (ko) | 2018-07-13 | 2021-03-24 | 소니 주식회사 | 유기인산염 단위를 포함하는 백본을 갖는 중합체성 염료 |
| WO2020092655A1 (en) * | 2018-10-30 | 2020-05-07 | Magenta Therapeutics, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
| WO2021062176A2 (en) | 2019-09-26 | 2021-04-01 | Sony Corporation | Polymeric tandem dyes with linker groups |
| EP4038081A1 (en) | 2019-09-30 | 2022-08-10 | Sony Group Corporation | Nucleotide probes |
| EP4256078A1 (en) | 2020-12-07 | 2023-10-11 | Sony Group Corporation | Spacing linker group design for brightness enhancement in dimeric or polymeric dyes |
| CN118043082A (zh) * | 2021-09-30 | 2024-05-14 | 索尼集团公司 | 用于癌症治疗的吡咯并苯并二氮杂䓬缀合物 |
| JP2025510189A (ja) | 2022-03-24 | 2025-04-14 | アクティニウム ファーマシューティカルズ インコーポレイテッド | ヒト化抗ｃｄ４５抗体 |
| IL321599A (en) | 2022-12-23 | 2025-08-01 | Cimeio Therapeutics Ag | Antibodies targeting cd45 |
| CN120554513B (zh) * | 2025-07-28 | 2025-11-21 | 杭州华大生命科学研究院 | 一种抗cd45抗体及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014020826A8 (pt) * | 2012-02-24 | 2017-09-19 | Stem Centrx Inc | Anticorpo que se liga especificamente a um epítopo, ácido nucleico, vetor ou célula hospedeira, conjugado de fármaco anticorpo, composição farmacêutica compreendendo o referido anticorpo, uso do mesmo, kit e método de preparação do conjugado |
| HK1256681A1 (zh) * | 2015-04-06 | 2019-10-04 | President And Fellows Of Harvard College | 用於非清髓性预处理的组合物和方法 |
| WO2017155937A1 (en) * | 2016-03-07 | 2017-09-14 | Actinium Pharmaceuticals, Inc. | Stabilized radiolabeled anti-cd45 immunoglobulin compositions |
| CN109641051A (zh) * | 2016-06-17 | 2019-04-16 | 美真达治疗公司 | 用于耗尽细胞的组合物和方法 |
| EP3877416A4 (en) * | 2018-10-30 | 2022-07-27 | Magenta Therapeutics, Inc. | ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF |
-
2020
- 2020-04-24 JP JP2021563185A patent/JP7650819B2/ja active Active
- 2020-04-24 WO PCT/US2020/029929 patent/WO2020219959A1/en not_active Ceased
- 2020-04-24 EP EP20795599.8A patent/EP3958910A4/en active Pending
-
2021
- 2021-10-22 US US17/508,641 patent/US20220175951A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022530089A5 (https=) | ||
| ES2795818T3 (es) | Anticuerpos CD48 y conjugados de los mismos | |
| US20230322920A1 (en) | Multi-specific antibodies and methods of making and using thereof | |
| CN113710277B (zh) | 一种负载双毒素的抗体药物偶联物及其应用 | |
| ES2955961T3 (es) | Anticuerpos anti-ntb-a y composiciones y métodos relacionados | |
| Mountain et al. | Engineering antibodies for therapy | |
| AU2005218642B2 (en) | Partially loaded antibodies and methods of their conjugation | |
| CN101903403B (zh) | Cd19结合剂及其应用 | |
| US6506881B1 (en) | Anti-HMFG antibodies and processes for their production | |
| WO2019108863A4 (en) | Compositions and methods for the depletion of cd5+ cells | |
| JP2022530438A5 (https=) | ||
| JP7799669B2 (ja) | 抗体薬物コンジュゲート | |
| CN110352201A (zh) | 用于癌症疗法的抗体药物缀合物的皮下施用 | |
| WO2019108860A4 (en) | Compositions and methods for the depletion of cd2+ cells | |
| Mezzanzanica et al. | Retargeting of human lymphocytes against human ovarian carcinoma cells by bispecific antibodies: from laboratory to clinic | |
| ES2528718T3 (es) | Diana para linfocitos B | |
| JP2023546293A5 (https=) | ||
| US20250339570A1 (en) | Radioimmunoconjugates and therapeutic uses thereof | |
| JP2024540536A5 (https=) | ||
| CANEVARI | MARINA RIPAMONTI, FRANCISCO CONDE* and MARIA INES | |
| KR20260022886A (ko) | 방사성동위원소 표지된 cd25 표적 항체를 유효성분으로 포함하는 암의 방사면역치료용 약제학적 조성물 | |
| Canevari et al. | Targeting of Toxin Proteins by Monoclonal Antibodies: Perspectives for Tumor Therapy | |
| Kummer et al. | Concepts of antibody-mediated cancer therapy | |
| Makino et al. | Expression of Tumor‐associated Glycoantigen, Sialyl Lewisa, in Human Head and Neck Squamous Cell Carcinoma and Its Application to Tumor Immunotherapy | |
| JP2023520399A5 (https=) |